New Coronavirus vaccine in China

According to the State Food and drug administration, in February 25th, the State Administration of medicines and Drug Administration approved the application of Conchino bio company to reorganize New Coronavirus vaccine. The vaccine is the first COVID-19 vaccine approved by the domestic adenovirus vector, which is suitable for preventing diseases caused by New Coronavirus infection.
 
It is reported that the vaccine was jointly developed by Chen Wei, academician of Chinese Academy of engineering and researcher of Academy of military medicine of Chinese Academy of Military Sciences, and kangxinuo biology. The vaccine is the only one of the new crown vaccines approved by the state for marketing, which can be inoculated with a single dose. It can obtain good protective effect after 14 days of single dose inoculation, and can be transported and stored at 2-8 ℃.